History

BIA Separations, Inc. shares nearly 20 years of history in the development of convective interaction media (CIM) monolith columns. As a distributor of these products, which are manufactured by Sartorius BIA Separations, we provide practical purification tools for vaccines, gene vectors, exosomes, and plasmid DNA.

Building on this background in liquid chromatography, BIA Separations, Inc. offers reliable products for downstream processing and analytics. Our goal is to help you save time and effort in your lab and production work.

Our Shared History and Milestones

• Early Innovations: Initial research introduces tubular shaped monoliths for biomolecular separation.
• 2007: BIA Separations, Inc. is established as a distribution partner to bring monolith technology directly to the biotech industry.
• Key Product Launches: The CIMmultus composite column line is introduced, followed by the PATfix system for process analysis.
• Regulatory Milestones: CIM technology is adopted for industrial cGMP purification and supports major approvals, including FDA clearance for pediatric gene therapies.
• 2020: Sartorius acquires BIA Separations. BIA Separations, Inc. continues to operate as an independent distributor, growing its product list to meet market needs.
• Industry Engagement: We continue to support the scientific community through events like the Monolith Summer Symposiums.